Outset Medical, Inc.
4.05 -0.17 (-4.03%)
- Market Cap
- $76.13M
- Volume
- 78.8K
- Dividend yield
- 0.00%
- Next earnings date
- Nov 4, 2026
Outset Medical, Inc. (OM) Stock Price, Analysis & Data
Intrinsic value
See plans →Analyst Forecast
Stock Forecasts →$6.00 – $10.00
Median $7.00 · 72.84% upside
You're seeing the free overview
Create a free account to explore more research on this ticker.
Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | $31.64M | n/a | +0.69% |
| EPS | -$0.80 | -$0.08 | +4.76% |
Metrics
- Bid
- 4.05
- Market Cap
- 76.1M
- Revenue (ttm)
- 118M
- Net Income (ttm)
- -74.3M
- 1.99
- -4
- n/a
- -1.77
- P/B (ttm)
- 0.79
- P/S (ttm)
- 0.65
- Earnings Date
- Nov 4, 2026
- Ask
- 4.1
- Volume
- 78,783
- Avg. Volume (20D)
- 156,546
- Open
- 4.30
- Previous Close
- 4.22
- Day's Range
- 3.99 - 4.35
- 52-Week Range
- 2.84 - 15.94
- Analyst
- n/a
- Price Target
- 7 (72.84%)
- Dividends
- n/a
- Ex-Dividend Date
- n/a
About Outset Medical, Inc.
View profile →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Industry Medical Devices
Sector Healthcare
IPO Date Sep 15, 2020
Employees 310
Stock Exchange NasdaqGS
Ticker Symbol OM
Website https://www.outsetmedical.com